About Biofluidica
Biofluidica is a company based in Chapel Hill (United States) founded in 2007 by Steven A Soper.. Biofluidica has raised $18.12 million across 11 funding rounds from investors including NIH, HHS and Mizzou. Biofluidica offers products and services including LiquidScan, Exosome Isolation, Fetal Cell Isolation, and CTC Isolation. Biofluidica operates in a competitive market with competitors including Guardant Health, GRAIL, Thrive Earlier Detection, Delfi Diagnostics and Abingdon Health, among others.
- Headquarter Chapel Hill, United States
- Founders Steven A Soper
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biofluidica, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$18.12 M (USD)
in 11 rounds
-
Latest Funding Round
-
Investors
NIH
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biofluidica
Biofluidica offers a comprehensive portfolio of products and services, including LiquidScan, Exosome Isolation, Fetal Cell Isolation, and CTC Isolation. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Automates isolation of rare cells and exosomes for diagnostics
Enables exosome extraction from samples for research analysis
Facilitates isolation of trophoblasts for prenatal testing
Supports isolation of circulating tumor cells from blood
Funding Insights of Biofluidica
Biofluidica has successfully raised a total of $18.12M across 11 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Last Round
-
First Round
First Round
(17 Sep 2015)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2022 | Amount | Grant - Biofluidica | Valuation |
investors |
|
| Dec, 2021 | Amount | Series B - Biofluidica | Valuation |
investors |
|
| Aug, 2021 | Amount | Grant - Biofluidica | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biofluidica
Biofluidica has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include NIH, HHS and Mizzou. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple courses and degrees are offered across diversified academic streams.
|
Founded Year | Domain | Location | |
|
Drug discovery services are provided to the biopharma sector.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biofluidica
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Biofluidica
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biofluidica Comparisons
Competitors of Biofluidica
Biofluidica operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, GRAIL, Thrive Earlier Detection, Delfi Diagnostics and Abingdon Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Circulating tumor DNA is screened for early cancer detection.
|
|
| domain | founded_year | HQ Location |
Blood-based liquid biopsy tests for multiple cancer detection are provided.
|
|
| domain | founded_year | HQ Location |
Provider of DNA sequencing for cancer detection
|
|
| domain | founded_year | HQ Location |
Developer of immunoassays for diagnostic purposes
|
|
| domain | founded_year | HQ Location |
Provider of cell-free cancer liquid biopsy test
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biofluidica
Frequently Asked Questions about Biofluidica
When was Biofluidica founded?
Biofluidica was founded in 2007 and raised its 1st funding round 8 years after it was founded.
Where is Biofluidica located?
Biofluidica is headquartered in Chapel Hill, United States. It is registered at Chapel Hill, North Carolina, United States.
Who is the current CEO of Biofluidica?
Greg Studdard is the current CEO of Biofluidica.
Is Biofluidica a funded company?
Biofluidica is a funded company, having raised a total of $18.12M across 11 funding rounds to date. The company's 1st funding round was a Grant of $250K, raised on Sep 17, 2015.
What does Biofluidica do?
Biofluidica was founded in 2007 and is based in Chapel Hill, United States, within the biotechnology sector. Operations focus on liquid biopsy systems that employ antibody-coated capture beds to isolate circulating tumor cells from blood samples. Clinical validation has been achieved for pancreatic, colorectal, ovarian, and breast cancers, enabling analysis for diagnostic purposes.
Who are the top competitors of Biofluidica?
Biofluidica's top competitors include Guardant Health, GRAIL and BillionToOne.
What products or services does Biofluidica offer?
Biofluidica offers LiquidScan, Exosome Isolation, Fetal Cell Isolation, and CTC Isolation.